Home › Proteostasis Therapeutics Announces Extension Of Funded Collaboration With Cystic Fibrosis Foundation Therapeutics For Novel Therapies Targeting Most Common CF Mutation
 

Keywords :   


Proteostasis Therapeutics Announces Extension Of Funded Collaboration With Cystic Fibrosis Foundation Therapeutics For Novel Therapies Targeting Most Common CF Mutation

2014-03-05 04:23:36| drugdiscoveryonline News Articles

Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with orphan and neurodegenerative diseases, recently announced an extension of its funded collaboration with Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT)

Tags: common foundation extension collaboration

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Hurricane Beryl Graphics
03.07Farm Progress America, July 3, 2024
03.07Farm Progress America, July 3, 2024
03.07Hurricane Beryl Forecast Discussion Number 19
03.07Hurricane Beryl Wind Speed Probabilities Number 19
03.07Hurricane Beryl Public Advisory Number 19
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Hurricane Beryl Forecast Advisory Number 19
More »